These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 25612920

  • 1. Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study.
    Suehiro Y, Hasegawa A, Iino T, Sasada A, Watanabe N, Matsuoka M, Takamori A, Tanosaki R, Utsunomiya A, Choi I, Fukuda T, Miura O, Takaishi S, Teshima T, Akashi K, Kannagi M, Uike N, Okamura J.
    Br J Haematol; 2015 May; 169(3):356-67. PubMed ID: 25612920
    [Abstract] [Full Text] [Related]

  • 2. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.
    Kannagi M, Hasegawa A, Nagano Y, Iino T, Okamura J, Suehiro Y.
    Cancer Sci; 2019 Mar; 110(3):849-857. PubMed ID: 30666755
    [Abstract] [Full Text] [Related]

  • 3. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
    Ishizawa M, Ganbaatar U, Hasegawa A, Takatsuka N, Kondo N, Yoneda T, Katagiri K, Masuda T, Utsunomiya A, Kannagi M.
    Cancer Sci; 2021 Mar; 112(3):1161-1172. PubMed ID: 33410215
    [Abstract] [Full Text] [Related]

  • 4. Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse model.
    Masaki A, Ishida T, Suzuki S, Ito A, Mori F, Sato F, Narita T, Yamada T, Ri M, Kusumoto S, Komatsu H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R.
    J Immunol; 2013 Jul 01; 191(1):135-44. PubMed ID: 23733874
    [Abstract] [Full Text] [Related]

  • 5. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y, Yamazaki R, Terasako-Saito K, Nakasone H, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Kimura S, Kikuchi M, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y.
    Immunol Lett; 2014 Jul 01; 158(1-2):120-5. PubMed ID: 24389072
    [Abstract] [Full Text] [Related]

  • 6. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
    Tanaka Y, Nakasone H, Yamazaki R, Sato K, Sato M, Terasako K, Kimura S, Okuda S, Kako S, Oshima K, Tanihara A, Nishida J, Yoshikawa T, Nakatsura T, Sugiyama H, Kanda Y.
    Cancer Res; 2010 Aug 01; 70(15):6181-92. PubMed ID: 20647322
    [Abstract] [Full Text] [Related]

  • 7. [Tax-targeted DC vaccine for ATL].
    Suehiro Y.
    Nihon Rinsho; 2017 Feb 01; 75(2):295-300. PubMed ID: 30562867
    [Abstract] [Full Text] [Related]

  • 8. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Tamai Y, Hasegawa A, Takamori A, Sasada A, Tanosaki R, Choi I, Utsunomiya A, Maeda Y, Yamano Y, Eto T, Koh KR, Nakamae H, Suehiro Y, Kato K, Takemoto S, Okamura J, Uike N, Kannagi M.
    J Immunol; 2013 Apr 15; 190(8):4382-92. PubMed ID: 23475215
    [Abstract] [Full Text] [Related]

  • 9. [HTLV-1-targeted immunotherapy].
    Suehiro Y.
    Rinsho Ketsueki; 2016 Apr 15; 57(10):2250-2258. PubMed ID: 27795537
    [Abstract] [Full Text] [Related]

  • 10. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
    Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, Ohashi T, Fukui F, Hasegawa A, Masuda T, Takaue Y, Okamura J, Kannagi M.
    Cancer Res; 2004 Jan 01; 64(1):391-9. PubMed ID: 14729650
    [Abstract] [Full Text] [Related]

  • 11. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.
    Ishihara Y, Tanaka Y, Kobayashi S, Kawamura K, Nakasone H, Gomyo A, Hayakawa J, Tamaki M, Akahoshi Y, Harada N, Kusuda M, Kameda K, Ugai T, Wada H, Sakamoto K, Sato M, Terasako-Saito K, Kikuchi M, Kimura SI, Tanihara A, Kako S, Uchimaru K, Kanda Y.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28724766
    [Abstract] [Full Text] [Related]

  • 12. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T, Fukada K, Hirata S, White Y, Harao M, Nishimura Y, Kino Y, Soeda S, Shimeno H, Lemonnier F, Sonoda S, Arima N.
    Mol Immunol; 2009 Dec 01; 47(2-3):606-13. PubMed ID: 19889459
    [Abstract] [Full Text] [Related]

  • 13. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
    Ando S, Hasegawa A, Murakami Y, Zeng N, Takatsuka N, Maeda Y, Masuda T, Suehiro Y, Kannagi M.
    J Immunol; 2017 Feb 01; 198(3):1210-1219. PubMed ID: 28011931
    [Abstract] [Full Text] [Related]

  • 14. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
    Kitazono T, Okazaki T, Araya N, Yamano Y, Yamada Y, Nakamura T, Tanaka Y, Inoue M, Ozaki S.
    Cell Immunol; 2011 Feb 01; 272(1):11-7. PubMed ID: 22030472
    [Abstract] [Full Text] [Related]

  • 15. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
    Yashiki S, Fujiyoshi T, Arima N, Osame M, Yoshinaga M, Nagata Y, Tara M, Nomura K, Utsunomiya A, Hanada S, Tajima K, Sonoda S.
    AIDS Res Hum Retroviruses; 2001 Jul 20; 17(11):1047-61. PubMed ID: 11485622
    [Abstract] [Full Text] [Related]

  • 16. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
    Furukawa Y, Kubota R, Tara M, Izumo S, Osame M.
    Blood; 2001 Feb 15; 97(4):987-93. PubMed ID: 11159527
    [Abstract] [Full Text] [Related]

  • 17. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M, Hasegawa A, Nagano Y, Kimpara S, Suehiro Y.
    Retrovirology; 2019 Aug 22; 16(1):23. PubMed ID: 31438973
    [Abstract] [Full Text] [Related]

  • 18. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
    Arnulf B, Thorel M, Poirot Y, Tamouza R, Boulanger E, Jaccard A, Oksenhendler E, Hermine O, Pique C.
    Leukemia; 2004 Jan 22; 18(1):126-32. PubMed ID: 14574331
    [Abstract] [Full Text] [Related]

  • 19. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
    Kurihara K, Shimizu Y, Takamori A, Harashima N, Noji M, Masuda T, Utsunomiya A, Okamura J, Kannagi M.
    J Immunol Methods; 2006 Jun 30; 313(1-2):61-73. PubMed ID: 16723135
    [Abstract] [Full Text] [Related]

  • 20. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
    Tanaka Y, Nakasone H, Yamazaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Sato M, Terasako K, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y.
    J Clin Immunol; 2012 Dec 30; 32(6):1340-52. PubMed ID: 22763862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.